▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3916 by analyst upside · 2026-09-28
VREX
Varex Imaging Corporation
Healthcare · Market Cap $783M · P/E 34.8x
ANALYST PRICE TARGET
+2.4%
implied upside to consensus target
Current Price $18.45
Consensus Target $18.9
Bull Target $18.9
Bear Target $18.9
Analysts Covering 2
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
0
Hold
2
Sell
0
52-Week Low $9.09
52-Week High $18.63
YTD Return +58.4%
FUNDAMENTALS
Market Cap $783M
P/E Ratio (TTM) 34.8x
Forward P/E 17.2x
EPS (TTM) $0.53
PEG Ratio 4.98
Dividend Yield N/A
Revenue (TTM) $865M
Profit Margin 2.6%
52-WEEK RANGE
52-Week Low $9.09
52-Week High $18.63
Current Price $18.45
Bear Target $18.9
Bull Target $18.9
● Now $18.45 ● Target $18.9
TRADING DATA
Avg Volume 848K
YTD Return +58.4%
Analyst Count 2
Consensus Hold
Upside to Target +2.4%
Last Updated 2026-09-28

ANALYST SUMMARY

Varex Imaging Corporation (VREX) is currently trading at $18.45 with a Wall Street consensus price target of $18.9, implying potential upside of 2.4% over the next 12 months. 2 analysts currently cover VREX, with a consensus rating of Hold - 0% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $18.9, while the most cautious has a target of $18.9.

VREX operates in the Healthcare sector with a market capitalisation of $783M. The stock is up 58.4% year-to-date and is currently trading near the upper end of its 52-week range of $9.09 – $18.63.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for VREX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

CJS Securities ↓ Downgrade
Outperform → Market Perform 2026-08-17 Building track record
Oppenheimer ↓ Downgrade
Outperform → Perform 2026-08-11 14% win rate (7 calls)
Sidoti & Co. ↓ Downgrade
Buy → Neutral 2026-08-10 Building track record
B. Riley Securities reit
Buy → Buy 2025-11-19 17% win rate (6 calls)
Oppenheimer - Reiterated
Outperform → Outperform 2025-11-19 14% win rate (7 calls)
B. Riley Securities - Reiterated
Buy → Buy 2025-08-08 17% win rate (6 calls)
Oppenheimer - Reiterated
Outperform → Outperform 2025-02-07 14% win rate (7 calls)
B. Riley Securities reit
Buy → Buy 2025-02-07 17% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
18
out of 100
Coverage depth
8/30
Consensus clarity
8/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →